SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-070863
Filing Date
2011-03-18
Accepted
2011-03-18 12:27:55
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 725291
2 THIRD AMENDMENT TO OFFICE LEASE dex1012.htm EX-10.12 9664
3 FOURTH AMENDMENT TO OFFICE LEASE dex1013.htm EX-10.13 17940
4 CONSENT OF MAYER HOFFMAN MCCANN P.C. dex231.htm EX-23.1 1426
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9565
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9582
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5380
8 GRAPHIC g162879g63c69.jpg GRAPHIC 39638
  Complete submission text file 0001193125-11-070863.txt   834762
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52228 | Film No.: 11697501
SIC: 8731 Services-Commercial Physical & Biological Research